The $66bn takeover of US seed company Monsanto by German drug giant Bayer is one of the largest M&A deals of all time. The task did not daunt Credit Suisse, however, which helped Bayer overcome regulatory and anti-trust hurdles and issue subsequent bonds. Edward Russell-Walling reports.

The Banker's articles are exclusively available to registered users and full subscribers

Register for FREE limited access to global banking and finance coverage

Gain easy and instant access to:

  • 3 free views each month
  • Latest headlines and trends
  • Weekly e-newsletter
 

  

 

 

Already registered? Click here to sign in

Need more? An annual subscription to The Banker provides a wealth of banking and finance knowledge covering a wide range of countries, markets and profiles.
Click here to find out more.

 

By continuing to use this site you consent to the use of cookies on your device as described in our cookie policy unless you have disabled them. You can change your cookie settings at any time but parts of our site will not function correctly without them.